Barakat syndrome: Clinical Trials

4 trials for Barakat syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Barakat syndrome: new trials by email Literature Review of Barakat syndrome trials Research Report on Barakat syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
HDR brachytherapy (30Gy single fraction), Immunotherapy - Advanced Stage NSCLC, Second-line Treatment
UnknownThe First People's Hospital of Neijiang802023-09-012024-07-24
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.
LDR Brachytherapy, HDR Brachytherapy - Adenocarcinoma of Prostate
Phase 2 / Phase 3UnknownNational Institute of Oncology, Hungary502014-09-012014-10-07
Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
Pindolol - Major Depressive Disorder, Antidepressant Treatment Response
Phase 2CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau302002-12-012009-07-02
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
HIgh Dose Rate Vs Low DOse Rate Brachytherapy - Cancer of Cervix, Cervical Cancer
Phase 3CompletedTata Memorial Hospital7501996-05-012015-05-06

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Depressive Disorder, Major (1)  ·  Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Depressive Disorder (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Drug Therapy (1)  ·  Immunotherapy (1)  ·  Pindolol (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  National Institute of Oncology, Hungary (1)  ·  Tata Memorial Hospital (1)  ·  The First People's Hospital of Neijiang (1)

Countries

China (1)  ·  Hungary (1)  ·  India (1)  ·  Spain (1)

Top investigators

Francesc Artigas, PhD (1)  ·  Peter Agoston, MD, PHD (1)  ·  Shyamkishore J Shrivastava, MD, DNB (RT) (1)

Results publications

PMID 21034693, PMID 25754329, PMID 25799953, PMID 28094262, PMID 28577836, PMID 29945993, PMID 30093664, PMID 30619280, PMID 30642458, PMID 31154919, PMID 33872070, PMID 33891980, PMID 34970277, PMID 35108059, PMID 35143424, PMID 35906199, PMID 35980349